- P53 expression in hepatocellular carcinoma: influence on the radiotherapeutic response of the hepatocellular carcinoma
-
Lee YR, Park SY
- KMID: 2351022
- Clin Mol Hepatol.
- 2015 Sep;21(3):230-231.
- doi: 10.3350/cmh.2015.21.3.230
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Managing alcoholic liver disease
-
Shah VH
- KMID: 2351020
- Clin Mol Hepatol.
- 2015 Sep;21(3):212-219.
- doi: 10.3350/cmh.2015.21.3.212
Alcoholic liver disease continues to be a significant cause of liver-related morbidity and mortality throughout the world. A number of diagnostic and prognostic models have been developed in the management... -
- CITED
-
- Close
- SHARE
-
- Close
- Sarcomatoid cholangiocarcinoma with osteoclast-like giant cells associated with hepatolithiasis: A case report
-
Kim HM, Kim H, Park YN
- KMID: 2351032
- Clin Mol Hepatol.
- 2015 Sep;21(3):309-313.
- doi: 10.3350/cmh.2015.21.3.309
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Portal flow steal after liver transplantation
-
Kim B, Kim KW, Song GW, Lee SG
- KMID: 2351033
- Clin Mol Hepatol.
- 2015 Sep;21(3):314-317.
- doi: 10.3350/cmh.2015.21.3.314
Portal flow steal occasionally persists even after the liver transplantation, which may reduce the portal flow and thus threaten the patients' outcome. Therefore, pre- and peri-operative detection of portal steal... -
- CITED
-
- Close
- SHARE
-
- Close
- Personalized management of cirrhosis by non-invasive tests of liver fibrosis
-
Wong GL, Espinosa W, Wong VW
- KMID: 2351019
- Clin Mol Hepatol.
- 2015 Sep;21(3):200-211.
- doi: 10.3350/cmh.2015.21.3.200
Owing to the high prevalence of various chronic liver diseases, cirrhosis is one of the leading causes of morbidity and mortality worldwide. In recent years, the development of non-invasive tests... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term outcomes of patients with advanced hepatocellular carcinoma who achieved complete remission after sorafenib therapy
-
Park JG
- KMID: 2351029
- Clin Mol Hepatol.
- 2015 Sep;21(3):287-294.
- doi: 10.3350/cmh.2015.21.3.287
BACKGROUND/AIMS: Sorafenib is currently the sole molecular targeted agent that improves overall survival in advanced hepatocellular carcinoma (HCC). Despite the efficacy of sorafenib, the response rate varies in patients with... -
- CITED
-
- Close
- SHARE
-
- Close
- Imaging findings for intravascular large B-cell lymphoma of the liver
-
Bae J, Lim HK, Park HY
- KMID: 2351030
- Clin Mol Hepatol.
- 2015 Sep;21(3):295-299.
- doi: 10.3350/cmh.2015.21.3.295
Intravascular large B-cell lymphoma (IVLBCL) is a rare subtype of extranodal diffuse large B-cell lymphoma that most commonly involves the central nervous system and skin. To our knowledge, no state-of-the... -
- CITED
-
- Close
- SHARE
-
- Close
- Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy
-
Park JG, Park SY
- KMID: 2351024
- Clin Mol Hepatol.
- 2015 Sep;21(3):242-248.
- doi: 10.3350/cmh.2015.21.3.242
BACKGROUND/AIMS: We compared the efficacies of entecavir (ETV) plus tenofovir (TDF) and ETV plus adefovir (ADV) in chronic hepatitis B (CHB) patients with genotypic resistance to lamivudine (LAM) who showed... -
- CITED
-
- Close
- SHARE
-
- Close
- The mutational landscape of hepatocellular carcinoma
-
Lee JS
- KMID: 2351021
- Clin Mol Hepatol.
- 2015 Sep;21(3):220-229.
- doi: 10.3350/cmh.2015.21.3.220
The development of hepatocellular carcinoma (HCC) is a complex process, and HCC arises from the accumulation of multiple genetic alterations leading to changes in the genomic landscape. Current advances in... -
- CITED
-
- Close
- SHARE
-
- Close
- Preference elicitation approach for measuring the willingness to pay for liver cancer treatment in Korea
-
Cho D, Jo C
- KMID: 2351027
- Clin Mol Hepatol.
- 2015 Sep;21(3):268-278.
- doi: 10.3350/cmh.2015.21.3.268
BACKGROUND/AIMS: The Korean government has expanded the coverage of the national insurance scheme for four major diseases: cancers, cardiovascular diseases, cerebrovascular diseases, and rare diseases. This policy may have a... -
- CITED
-
- Close
- SHARE
-
- Close
- From DCPD to NTCP: The long journey towards identifying a functional hepatitis B virus receptor
-
Li J, Tong S
- KMID: 2351018
- Clin Mol Hepatol.
- 2015 Sep;21(3):193-199.
- doi: 10.3350/cmh.2015.21.3.193
Hepatitis B virus (HBV) is the prototype of hepatotropic DNA viruses (hepadnaviruses) infecting a wide range of human and non-human hosts. Previous studies with duck hepatitis B virus (DHBV) identified... -
- CITED
-
- Close
- SHARE
-
- Close
- Influence of P53 on the radiotherapy response of hepatocellular carcinoma
-
Gomes AR, Abrantes A, Brito AF, Laranjo M, Casalta-Lopes JE, Goncalves , Sarmento-Ribeiro AB, Botelho MF, Tralhao JG
- KMID: 2351026
- Clin Mol Hepatol.
- 2015 Sep;21(3):257-267.
- doi: 10.3350/cmh.2015.21.3.257
BACKGROUND/AIMS: Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, and it has a poor prognosis and few therapeutic options. Radiotherapy is one of the most effective forms... -
- CITED
-
- Close
- SHARE
-
- Close
- A case of hepatoblastoma misdiagnosed as combined hepatocellular carcinoma and cholangiocarcinoma in an adult
-
Park KW, Seo CJ, Yun DY, Kim MK, Kim BS, Han YS, Oh HK, Lee CH
- KMID: 2351031
- Clin Mol Hepatol.
- 2015 Sep;21(3):300-308.
- doi: 10.3350/cmh.2015.21.3.300
Hepatoblastoma usually occurs in children under the age of 2 years, with very few cases reported in adults. We experienced a case of adult hepatoblastoma in a 36-year-old female with... -
- CITED
-
- Close
- SHARE
-
- Close
- Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease
-
An C, Choi YA, Choi D, Paik YH, Ahn SH, Kim MJ, Paik SW, Han KH, Park MS
- KMID: 2351028
- Clin Mol Hepatol.
- 2015 Sep;21(3):279-286.
- doi: 10.3350/cmh.2015.21.3.279
BACKGROUND/AIMS: The goal of this study was to estimate the growth rate of hepatocellular carcinoma (HCC) and identify the host factors that significantly affect this rate. METHODS: Patients with early-stage HCC... -
- CITED
-
- Close
- SHARE
-
- Close
- Static and dynamic prognostic factors for hepatitis-B-related acute-on-chronic liver failure
-
Ha JM, Sohn W, Cho JY, Pyo JH, Choi K, Sinn DH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC, Paik YH
- KMID: 2351023
- Clin Mol Hepatol.
- 2015 Sep;21(3):232-241.
- doi: 10.3350/cmh.2015.21.3.232
BACKGROUND/AIMS: Hepatitis-B-related acute-on-chronic liver failure has a poor prognosis. However, the advent of potent oral antiviral agents means that some patients can now recover with medical treatment. We aimed to... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison and analysis of the prevalence of hepatitis C virus infection by region in the Republic of Korea during 2005-2012
-
Shon HS, Choi HY, Kim JR, Ryu SY, Lee YJ, Lee MJ, Min HJ, Lee J, Song YJ, Ki M
- KMID: 2351025
- Clin Mol Hepatol.
- 2015 Sep;21(3):249-256.
- doi: 10.3350/cmh.2015.21.3.249
BACKGROUND/AIMS: This study compared the prevalence of hepatitis C virus (HCV) infection in the Republic of Korea and estimated the high-risk regions and towns. METHODS: National Health Insurance Service data for... -
- CITED
-
- Close
- SHARE
-
- Close
